Dermatology · Rochester, NY
NPI
1588771471
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
300 White Spruce Blvd
Rochester, NY, 14623
Phone (585) 424-6770
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
1,144 services
Medicare patients, 2024
257
Average age 74
Drug cost, 2024
$1.9M
1,619 prescriptions
Company payments, 2025
$1,074
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Beth H Lertzman was code 17003 (destruction skin lesion), 370 times for 65 patients. In total Beth H Lertzman billed 1,144 services in 47 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 370 | 65 | $2.94 | $1,087 |
| 99213 Office E&M - Established | Office | 220 | 175 | $51.20 | $11K |
| 17000 Destruction Skin Lesion | Office | 112 | 89 | $33.48 | $3,750 |
| 99214 Office E&M - Established | Office | 87 | 62 | $76.10 | $6,620 |
| 17110 Destruction Skin Lesion | Office | 80 | 69 | $55.48 | $4,439 |
| 11102 Skin Biopsy | Office | 72 | 56 | $38.45 | $2,768 |
| 11103 Skin Biopsy | Office | 35 | 19 | $26.50 | $928 |
| 99203 Office E&M - New | Office | 24 | 24 | $64.31 | $1,543 |
| 99204 Office E&M - New | Office | 21 | 21 | $110.35 | $2,317 |
| 17004 Destruction Skin Lesion | Office | 16 | 12 | $96.55 | $1,545 |
| 17262 Destruction Skin Lesion | Office | 13 | 12 | $97.82 | $1,272 |
By year: 2022 $63K for 1,423 services; 2023 $41K for 1,027 services; 2024 $44K for 1,144 services.
Medicare prescription drug claims, 2024
In 2024, the drug Beth H Lertzman prescribed most often to Medicare patients was Triamcinolone Acetonide, with 163 prescriptions and refills. In total Beth H Lertzman wrote 1,619 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 163 | 184 | 105 | $1,264 |
| Ketoconazole Generic | 154 | 165 | 76 | $3,592 |
| Clobetasol Propionate Generic | 125 | 142 | 65 | $5,248 |
| Minoxidil Generic | 114 | 230 | 25 | $620 |
| Dutasteride Generic | 86 | 158 | 21 | $1,349 |
| Doxycycline Hyclate Generic | 59 | 62 | 19 | $1,377 |
| Fluorouracil Generic | 54 | 62 | 47 | $3,477 |
| Hydrocortisone Generic | 53 | 62 | 41 | $692 |
| Dupixent Pen Dupilumab | 51 | 65 | 11 | $226K |
| Otezla Apremilast | 44 | 58 | Under 11 | $249K |
| Desonide Generic | 39 | 44 | 34 | $2,374 |
| Imiquimod Generic | 38 | 50 | 30 | $843 |
| Valacyclovir Valacyclovir Hcl | 30 | 35 | 22 | $270 |
| Fluocinolone Acetonide Generic | 30 | 33 | 22 | $1,522 |
| Betamethasone Dipropionate Generic | 27 | 27 | 16 | $1,448 |
Brand drugs: 243 claims; generic drugs: 1,376 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Beth H Lertzman $1,074 ($1,074 in general payments such as food, travel and fees) from 8 companies. The largest payer was Janssen Biotech, Inc. with $197.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.